Skip to the page

Data / Form D filings / Apicore Inc.

Apicore Inc.: Form D filings

Apicore Inc., a pharmaceuticals company in Somerset, NJ, filed 4 Form D notices with the SEC between 2014 and 2016. The latest, on October 7, 2016, reports $720,118 sold of a $720,118 offering to 4 investors.

Find out what Apicore Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
49 NAPOLEON COURT, WORLDS FAIR DRIVE, Somerset, NJ, 08873
Phone
(732) 748-8882
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2014
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1613021

The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 7, 2016New notice$720,118$720,118$04Sep 26, 2016sec.gov
Jul 15, 2014New notice$6,826,400$6,826,400$01Jul 3, 2014sec.gov
Jul 15, 2014New notice$12,500$12,500$012Jul 3, 2014sec.gov
Jul 15, 2014New notice$9,200,037$9,200,037$02Jul 3, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Albert FriesenExecutive Officer, Director
Vithal DahdukDirector
Timothy B. SawyerDirector
Ravishanker KoviExecutive Officer, Director
Theron E. OdlaugDirector
James GaleExecutive Officer
Todd SoneDirector

Other pharmaceuticals companies in New Jersey that filed recently

Every Form D from the week of Oct 3, 2016 · All recent filings in New Jersey · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Apicore Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.